Friday, January 20, 2006
Just a high level overview of course. This is a Paul Krugman piece on how the new Medicare drug benefit is thinly discussed welfare - for the drug companies of course. The way this program is run only serves to point out how inefficient our medical system is in the United States.

0 Comments:
Post a Comment
<< Home